Navigation Links
Upcoming Webinar to Inform Public About Access to Investigational Drugs
Date:2/19/2010

First in the 'FDA Basics' Series of Online Sessions for the Public

SILVER SPRING, Md., Feb. 19 /PRNewswire-USNewswire/ -- Do you have questions about the use of investigational drugs for treatment purposes? Here is your opportunity to ask experts from the Food and Drug Administration (FDA) about this important topic, or to just listen in to learn more about investigational drugs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

When: Tuesday, Feb. 23, 2010, at 3 p.m. ET

Where: https://webmeeting.nih.gov/expandedaccess/

Host: FDA's Office of Special Health Issues (OSHI), 301-827-4460, OSHI@oc.fda.gov

Speakers:

Richard Klein, HIV/AIDS program director, OSHI

Theresa Toigo, R.Ph., M.B.A., director, OSHI

Also known as experimental drugs, investigational drugs are new drugs that are in the process of being tested for safety and effectiveness. They either have not yet been approved by FDA, or are approved drugs that have not yet been approved for a new use.

Investigational drugs may sometimes be used outside of clinical trials to treat a patient with a serious or immediately life-threatening disease or condition who has no other comparable or satisfactory treatment options. This use is called expanded access, or "compassionate use."

During this webinar, FDA experts will present information on

  • factors to consider in deciding whether to seek access to an investigational drug
  • ways to access investigational drugs
  • how the agency protects patients using investigational drugs

The presentation will run 30 minutes and will include an opportunity to ask questions.

To join the webinar:

  1. Click https://webmeeting.nih.gov/expandedaccess/ (or cut and paste it into your Internet browser).
  2. Click "Enter as a Guest," fill in your name, then click "Enter Room."
  3. Once you enter the meeting room, a popup will appear inviting you to join the teleconference. Type your own telephone number, then click "Call my phone" or "Call me." Answer your phone when it rings and follow the voice prompts to join the teleconference.

NOTE: If your phone number includes an extension, or if you will attend the teleconference only (not the online visual portion), please use the manual dial-in number: 1-866-628-8620 and passcode: 340910

To verify your ability to access the webinar (recommended for first-time Connect users):

  1. Click http://nihbreeze.cit.nih.gov/common/help/en/support/meeting_test.htm (or cut and paste it into your Internet browser).
  2. If any failures are indicated, click "Send Results" to submit your test results to Tech Support. Then e-mail webmeeting@mail.nih.gov and indicate that you would like assistance with troubleshooting your computer.

This webinar is the first in a series of monthly online sessions hosted by different FDA centers and offices. The webinar series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.

Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.


View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

SOURCE U.S. Food and Drug Administration

Back to top

RELATED LINKS
http://www.fda.gov/AboutFDA/Basics

'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
4. IDM Pharma Announces Upcoming Clinical Data Presentations
5. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
8. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
9. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
10. Genmab Announces Upcoming Ofatumumab Studies
11. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
(Date:5/10/2017)... May 10, 2017 Radiology has become the ... costs have also spiraled to the number one ranking ... radiology than ever before as the most complete and ... patient with lower back pain an MRI may confirm ... for pain, resulting in entirely different treatment protocols.  In ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... May 24, 2017 , ... Fiberstar, Inc., ... the food and beverage industry offers Citri-Fi®, a natural citrus fiber, to improve ... decision process. As a result, labels need to deliver simple, transparent and clear ...
(Date:5/23/2017)... , ... May 23, 2017 , ... Allegheny Health ... open The Alexis Joy D’Achille Center for Women’s Behavioral Health at West Penn ... in western Pennsylvania for women suffering from pregnancy-related depression. Construction of the Center ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... body for exercise professionals, is pleased to announce the organization’s Certified Strength Coach ... The NCSF Certified Strength Coach (CSC) program validates the competency of qualified candidates ...
(Date:5/23/2017)... York (PRWEB) , ... May 23, 2017 , ... ... LifeLabs, a leading equipment provider in the modern ART laboratory, to provide hands-on ... in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing vendor ...
Breaking Medicine News(10 mins):